stockweiser, taking on Cotara to most big pharmas would be a bit like your town taking on building a nuclear reactor. Regulatory agencies. I131 has medical uses now, but mainly for taming overactive thyroids, and for some thyroid cancers. But how do you tell a patient they can't walk through an airport security scanner for 8 days after taking a medication? I am sure there are other issues with Cotara such as MAB size, immunogenicity (causing allergic reactions with multiple use), and possible bone marrow suppression, but these are only educated guesses and nothing I have seen in writing. I think a frank discussion of that technology is long overdue.
News 
Market Data 
Discover 
AI
